Vaccine Efficacy and Safety
A section of Vaccines (ISSN 2076-393X).
Section Information
Aims
The Vaccine Efficacy and Safety section aims to examine the features and attributes of how vaccination protects people against infection, symptomatic illness, hospitalization, and death.
Scope
Vaccines are among the most effective, safe, and cost-effective means to train the body’s immune system to fight a disease it has never been exposed to. Vaccines are designed to prevent disease, rather than treat them. Vaccination programs have increased health by achieving high levels of individual and community protection. However, limited knowledge and misperceptions of vaccine effectiveness and safety are sometimes associated with vaccine hesitancy or delay in the acceptance or refusal of vaccinations despite the availability of vaccination services.
The manuscripts considered for submission to this section include those about the following or related themes: vaccine efficacy and safety; studies assessing vaccine efficacy and safety; methods for assessing vaccine efficacy and safety; effectiveness of vaccination programs; knowledge and perception of vaccine efficacy, vaccine safety monitoring; and communication of vaccine effectiveness and safety.
Keywords
- vaccine efficacy
- vaccine effectiveness
- vaccine safety
- evaluative studies
- clinical trials
- post-marketing studies
- vaccine safety research
- monitoring systems
- communication strategies
Editorial Board
Special Issues
Following special issues within this section are currently open for submissions:
- Research in Vaccine Epidemiology: Immunogenicity, Effectiveness, and Safety (Deadline: 28 November 2024)
- COVID-19 Vaccine-Associated Autoimmune Diseases and Disorders (Deadline: 30 November 2024)
- Pharmacovigilance Challenges of COVID-19 Vaccine (Deadline: 30 November 2024)
- Factors That Contribute to Vaccine Hesitancy towards COVID-19 Vaccination (Deadline: 30 December 2024)
- Promoting Research, Development and Access to Vaccines to Address Global Inequities (Deadline: 31 December 2024)
- Vaccines and Vaccination: Feature Papers (Deadline: 31 January 2025)
- Efficacy, Immunogenicity and Safety of COVID-19 Vaccines and COVID-19 Vaccination Strategies (Deadline: 31 January 2025)
- Vaccine Efficacy and Safety in Patients with Immune-Mediated Intestinal Diseases (Deadline: 31 January 2025)
- Vaccine Efficacy and Safety in People with Kidney Diseases/Kidney Transplant Recipients (Deadline: 31 January 2025)
- Pharmacoepidemiology in Vaccine Safety and Efficacy (Deadline: 31 January 2025)
- Vaccine Efficacy and Safety in Transplant Recipients (Deadline: 31 January 2025)
- Effectiveness and Safety of Vaccines in Special Populations (Deadline: 30 March 2025)
- Vaccine-Induced Immune Thrombotic Thrombocytopenia (Deadline: 31 March 2025)
- Safety and Side Effects in SARS-CoV-2 Vaccine (Deadline: 31 May 2025)
- Evaluation of Vaccine Efficacy, Safety and Immunogenicity Against Influenza, RSV and COVID-19 (Deadline: 30 June 2025)
- Clinical Strategies to Improve Efficacy, Effectiveness, and Safety of Vaccination in Humans (Deadline: 31 July 2025)
Topical Collection
Following topical collection within this section is currently open for submissions:
